Back to News
Market Impact: 0.55

CrowdStrike's Outlook, Buyback Plan Impress, But Some Analysts Say Valuation Limits Upside

CRWDBACRYTFC
Technology & InnovationCybersecurity & Data PrivacyCorporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Company FundamentalsAnalyst EstimatesAnalyst Insights

CrowdStrike's stock traded lower after Q1 earnings, despite some strong results; NNARR beat expectations at $193.8M versus the $176.7M consensus, though it declined 8.5% year-over-year. Analysts downgraded the stock due to valuation concerns, despite healthy ARR growth of 22% and management reaffirming full-year revenue guidance of $4.74B-$4.81B, coupled with a new $1B share buyback program. Management expects NNARR growth to double in Q2, and analysts cite the adoption of Falcon Flex, which reached a total deal value of $3.2B, as a positive sign.

Analysis

CrowdStrike Holdings (CRWD) experienced a 4% share price decline to $469.01 despite reporting Q1 results that showcased robust underlying fundamentals. The company's Net New Annual Recurring Revenue (NNARR) for Q1 was $193.8 million, surpassing the consensus estimate of $176.7 million, although this represented an 8.5% year-over-year decrease. Annual Recurring Revenue (ARR) grew 22% to $4.44 billion, exceeding Street expectations by 100 basis points. Key growth drivers included a tripling of Next-Gen SIEM ARR year-on-year, accelerated Cloud Security growth, and a 31% sequential increase in Falcon Flex adoption, with Falcon Flex accounts now representing a total deal value exceeding $3.2 billion. Q1 revenue reached $1.1 billion, in line with the company's guidance midpoint but slightly below some Street estimates of $1.105.3 billion, partly due to an ~$11 million headwind from discontinued programs. Earnings per share of 73 cents beat the consensus of 67 cents, and the non-GAAP operating margin of 18.2% significantly exceeded guidance. Management reaffirmed full-year revenue guidance of $4.74 billion to $4.81 billion and announced a new $1 billion share repurchase program. They project Q2 NNARR sequential growth to double, suggesting approximately $204.6 million, and anticipate NNARR reacceleration in the second half of fiscal 2026. Despite these strong operational metrics and positive outlook, BofA Securities and Canaccord Genuity downgraded the stock to Neutral/Hold respectively, citing valuation concerns as the primary reason, even while raising price targets to $470 and $475. Other analysts, such as RBC, Truist, Needham, Rosenblatt, and JMP, maintained Buy/Outperform ratings with price targets ranging from $500 to $530, emphasizing strong execution and growth prospects. The U.S. Fed investigation remains an unresolved item.